Agilent Technolgies, the Santa Clara, US-based scientific instrument manufacturer, has acquired instrument manufacturer and contract research organisation (CRO), Biocius Life Sciences, for an undisclosed amount.
The American Society for Mass Spectrometry meeting (ASMS) was the
scene of a lot of activity from Agilent this week as the lab
instrument specialist unleashed new mass spectrometer products at
Agilent Technologies has signed an agreement with Groton Biosystems
to co-market measuring solutions for the pharmaceutical industry,
as the Process Analytical Technology (PAT) initiative gains
popularity among drug manufacturers...
Agilent has launched a new line of HPLC columns, which is set to
deliver industry-leading separation performance for analytical,
high-resolution and fast LC applications, including pharmaceutical,
QA/QC, environmental and food-safety...
Agilent introduces its next generation of assay kits for its 2100
Bioanalyser Lab-on-a-Chip platform that aims to replace
labour-intensive SDS-PAGE and capillary gel electrophoresis (CGE)
methods providing faster microfluidic analyses.
Agilent have dived in to grab a slice of the growing $1.3 bn mass
spectrometry market with the launch of a series of new liquid
chromatography-based mass spectrometry (LC/MS) systems that are
cheaper and faster.
Agilent has launched a Laboratory Resource Management (LRM) service
for life science and pharmaceutical laboratories that promises to
improve productivity, reduce service costs and simplfy
A hive of activity at Agilent Technologies has trnsformed the
company into a significant player in the competitive microarray
platform market with the expansion of its array-based genomics,
disease research and drug R&D applications.
Agilent Technologies has launched what it claims is the industry's
first fully automated, high-throughput 'lab-on-a-chip system' for
basic life science research and drug discovery. The Agilent 5100